100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Advanced Pathophysiology 530 - Exam 3: Graded Questions with Answers | Advanced Pathophysiology Exam 3 and NSG 530 Exam 3 Questions from the Best Institutions Across the Globe for Comprehensive Preparation £21.15   Add to cart

Exam (elaborations)

Advanced Pathophysiology 530 - Exam 3: Graded Questions with Answers | Advanced Pathophysiology Exam 3 and NSG 530 Exam 3 Questions from the Best Institutions Across the Globe for Comprehensive Preparation

 1 view  0 purchase
  • Module
  • Advanced Pathophysiology 530
  • Institution
  • Advanced Pathophysiology 530

Advanced Pathophysiology 530 - Exam 3: Graded Questions with Answers | Advanced Pathophysiology Exam 3 and NSG 530 Exam 3 Questions from the Best Institutions Across the Globe for Comprehensive Preparation

Preview 3 out of 21  pages

  • November 15, 2024
  • 21
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • Advanced Pathophysiology 530
  • Advanced Pathophysiology 530
avatar-seller
Advanced Pathophysiology 530 - Exam 3, Advanced
Pathophysiology Exam 3, NSG 530 Exam 3 EXAMS
FROM THE BEST INSTITUTIONS ACROSS THE GLOBE
Graded questions with answers
how does collagen contribute to ECM remodeling - CORRECT ANSWER- --remodeling
results in the deposition of collagen btw myocytes, which can disrupt the integrity of the
muscle, decrease contractility, and make the ventricle more likely to dilate and fail



how does collagen contribute to fibrosis - CORRECT ANSWER- --fibroblast dysfunction
results in collagen imbalance

-matrix metalloproteinases - these become active and start degrading some of the proteins
in the ECM - change in shape and geometry

-causes slippage and over stretching

-excessive fibrosis (thickening of ventricular wall)

-seen post infarct

-small changes in volume accompanied by large change in pressure



vascular changes in HF - CORRECT ANSWER- --loss of ability to vasodilate (endothelial
dysfunction)

-imbalance in vasoconstrictors (endothelin) and vasodilators (nitric oxide)

-oxidative stress

-persistent vasoconstriciton



left ventricular remodeling - CORRECT ANSWER- -change in LV geometry, mass, and
volume that occurs over a period of time

,remodeling - CORRECT ANSWER- -muyocardium and vasculature-compensatory response
that results in structural and functional changes



long term clinical consequences with remodeling - CORRECT ANSWER- --return to fetal
proteins phenotype

-change in the number of pumps and receptors - HFrEF should be on a beta blocker

-loss of myocardial contractile force - poor CO and inotropic response to adrenergic stimuli

-contractile protein synthesis is not matched with increased mitochondrial synthesis - ATP
deficient

-myocardial energetics



activation of RAAS in HF - CORRECT ANSWER- -causes not only increases in preoload and
afterload, but also causes direct toxicity to the myocardium



angiotensin II in HF - CORRECT ANSWER- -mediates remodeling of the ventricular wall,
contributing to the sacromere death, loss of the normal collagen matrix, and interstitial
fibrosis

-leads to decreased contractility, changes in myocardial compliance, and ventricular
dilation

HFrEF



speak to the cascade and effects of RAAS in HF - CORRECT ANSWER- --triggered by a drop
in BP because of hypoperfusion and poor SV

-angiotensinogen

-renin converts to angiotensin

-then angiotensin I then II

-binds to AT I receptor triggering:

- vasoconstriction

, - oxidative stress

- cell growth (hypertrophy)

- proteinuria

- LV remodeling

- vascular remodeling



what does Angiotensin II do in HF - CORRECT ANSWER- --increased antidiuretic hormone

-vasoconstriction

-increased Na reabsorption

-increased aldosterone secretion



what does aldosterone lead to - CORRECT ANSWER- --sodium and water retention

-potassium and magnesium loss

-reduced baroreceptor reflex

-cardiac fibrosis

-ischemia

-sympathetic activation



pharmacological treatment of stage A HF - CORRECT ANSWER- -angiotensin converting
enzyme inhibitors (pril)

angiotensin II receptor blockers (sartan)

statins as appropriate

at risk for HF but without structural heart disease or symptoms of HF



pharmacological treatment of stage B HF - CORRECT ANSWER- -ACEI (pril)

ARBs (sartan)

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller qualityexamshut. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £21.15. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75057 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£21.15
  • (0)
  Add to cart